Search clinical trials for: Platinum (cisplatin or carboplatin)
Total 1212 results
-
Fundacao ChampalimaudNot yet recruitingTriple Negative Breast Cancer | Early Breast CancerPortugal
-
Guangzhou First People's HospitalRecruitingUlcerative Colitis | Fecal Microbiota TransplantationChina
-
Hoffmann-La RocheGilead Sciences; Seagen Inc.RecruitingBreast CancerKorea, Republic of, Spain, United States, Israel, United Kingdom, France, Australia, Germany
-
Samsung Medical CenterRecruitingNewly Diagnosed High Risk NeuroblastomaKorea, Republic of
-
Dana-Farber Cancer InstituteChildren's Hospital of Philadelphia; Boston Children's HospitalCompletedNeuroblastoma | Ewings Sarcoma | Non-rhabdomyosarcoma Soft Tissue SarcomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterAstraZenecaRecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompletedDiseases of Oesophagus Stomach and DuodenumUnited States
-
EpicentRx, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Ovarian Epithelial Cancer | Neuroendocrine Tumors | Small Cell CarcinomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedCentral Nervous System Tumor, PediatricUnited States
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerDenmark, Italy, Spain, United States, Korea, Republic of, Japan, Netherlands, Norway, Sweden
-
Genentech, Inc.Active, not recruitingAdvanced/Metastatic TumorsSpain, United States, Korea, Republic of, Australia, France, Japan, Canada
-
Checkpoint Therapeutics, Inc.TerminatedMetastatic Non-squamous Non Small Cell Lung CancerPeru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
-
Astex Pharmaceuticals, Inc.CompletedOvarian CancerCanada, United States, United Kingdom
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany
-
Merck Sharp & Dohme LLCActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC) | Gastroesophageal Junction Carcinoma (GEJC) | Esophageal Adenocarcinoma (EAC)China, Canada, United States, Argentina, Belgium, Brazil, Chile, Czechia, Denmark, Estonia, France, Germany, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Philippines, Portugal, Romania, Russian Federation and more
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Cancer | Gastroesophageal Junction CancerChina
-
Roswell Park Cancer InstituteRecruitingEsophageal AdenocarcinomaUnited States
-
Toray Industries, IncRecruitingMelanoma | Renal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Cholangiocarcinoma | Bladder Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer | Palpable Subcutaneous Malignant LesionsUnited States, France
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Cancer | Gastroesophageal Junction CancerUnited States, Belgium, Brazil, Canada, Chile, China, Estonia, France, Germany, Guatemala, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Philippines, Poland, Russian Federation, Singapore, Taiwan, Ukraine, United...
-
M.D. Anderson Cancer CenterSpectrum Pharmaceuticals, IncWithdrawn
-
Washington University School of MedicineGenentech, Inc.Terminated
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Cardiac ToxicityUnited States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
-
Merck Sharp & Dohme LLCGynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerPoland, Korea, Republic of, United States, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine
-
University of ChicagoActive, not recruitingHNSCC | HPV-Related Squamous Cell CarcinomaUnited States
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
Bristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States, Canada
-
Merck Sharp & Dohme LLCCompleted
-
Guangdong Association of Clinical TrialsChinese Thoracic Oncology GroupRecruitingCarcinoma, Non-Small-Cell LungChina
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerCanada, Belgium, Korea, Republic of, United States, France, Brazil, China, New Zealand, Israel, Spain, Argentina, Serbia, Mexico, Italy, Japan, Peru, Turkey, Taiwan, Costa Rica, Thailand, Australia, Germany, Hong Kong, Netherlands, Poland, Russian Federation and more
-
Merck Sharp & Dohme LLCCompleted
-
Taiho Oncology, Inc.RecruitingPancreatic Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Cancer | Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer | Siewert Type 1 GEJ CancerUnited States, Spain, Germany, France
-
Drexel University College of MedicineCompletedHead and Neck CancerUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Triple-Negative Breast CarcinomaUnited States
-
St. Jude Children's Research HospitalActive, not recruitingRetinoblastomaUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk NeuroblastomaFrance, Spain, United Kingdom, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Belgium, Denmark, Greece, Lithuania
-
Cancer Trials IrelandSouthampton Clinical Trials Unit; Region H Rigshospitalet; Centre Hospitalier...CompletedOesophageal Cancer | Adenocarcinoma of the Oesophagus | Adenocarcinoma of the Oesophago-gastric Junction | Oesophageal Tumours | Junctional TumoursIreland, United Kingdom, Denmark, France, Sweden
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRecruitingNon-squamous NSCLCChina
-
Leiden University Medical CenterCanadian Institutes of Health Research (CIHR); AstraZeneca; National Cancer Institute... and other collaboratorsRecruitingEndometrial CancerNetherlands, Canada, France, United Kingdom
-
Markus MaparaITB-Med LLCRecruiting
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsBrazil, Canada, United States, United Kingdom, Taiwan, Australia, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Russian Federation, Singapore, Spain, Sweden, Turkey
-
Sungkyunkwan UniversityMinistry of Food and Drug Safety, KoreaUnknownCarcinoma, Non-Small-Cell Lung | Immune-Related Adverse Events
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
University of ArkansasActive, not recruitingUARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionMultiple MyelomaUnited States
-
St. Jude Children's Research HospitalGenentech, Inc.CompletedOsteosarcoma | Malignant Fibrous Histiocytoma (MFH) of BoneUnited States
-
Weiguo LvShandong University; Huazhong University of Science and Technology; First Affiliated...RecruitingGestational Trophoblastic NeoplasmsChina
-
University of ArkansasActive, not recruitingMyelomaUnited States